•
Sep 30, 2023

Akoya Q3 2023 Earnings Report

Akoya reported record revenue with strong financial performance and maintained stable operating expenses.

Key Takeaways

Akoya Biosciences reported a record revenue of $25.2 million for Q3 2023, a 34% increase compared to the previous year. The company is focused on improving workflow throughput and expanding its menu of ready-to-use panels.

Total revenue reached $25.2 million, a 34% increase year-over-year.

Product revenue increased by 25% to $18.0 million.

Service and other revenue increased by 62% to $7.2 million.

Gross profit increased by 40% to $15.3 million with a gross profit margin of 60.6%.

Total Revenue
$25.2M
Previous year: $18.9M
+33.8%
EPS
-$0.26
Previous year: -$0.47
-44.7%
Gross Profit
$15.3M
Previous year: $10.9M
+40.1%
Cash and Equivalents
$78.6M
Previous year: $51.8M
+51.6%
Free Cash Flow
-$14.6M
Previous year: -$16M
-8.6%
Total Assets
$177M
Previous year: $176M
+0.4%

Akoya

Akoya

Akoya Revenue by Segment

Forward Guidance

The company continues to expect full year 2023 revenue in the range of $95-98 million.